Macaque animal model for HIV-induced neurological disease

Journal of Neural Transmission

Volumn 109, Issue 5-6, 2002, Pages 747-766

  Sopper, S ^a   Koutsilieri, E ^a,b   Scheller, C ^a   Czub, S ^b   Riederer, P ^b   Ter Meulen, V ^a  

^a Institut fur Virologie und Immunbiologie   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Brain; Cerebrospinal fluid; Dementia; HIV; SIV

Indexed keywords

ANTIVIRUS AGENT; CYTOKINE; GAG PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN NERVE CELL; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DEMENTIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACACA; MICROGLIA; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 0036322224     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020200062     Document Type: Article

References (137)

1. Neurovirulent simian immunodeficiency virus infection induces neuronal, endothelial, and glial apoptosis
2. Immunologic NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41
3. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage
4. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: Identification by the combination of in situ polymerase chain reaction and immuno-chemistry
5. Disseminated cytomegalovirus infection in immunodeficient rhesus monkeys
6. Correlates of SIV encephalitis in rhesus monkeys
7. Fractionator analysis shows loss of neurons in the lateral geniculate nucleus of macaques infected with neurovirulent simian immunodeficiency virus
8. Neurovirulent simian immunodeficiency virus induces calbindin-D-28K in astrocytes
9. Microglial activation and neurological symptoms in the SIV model of NeuroAIDS: Association of MHC-II and MMP-9 expression with behavioral deficits and evoked potential changes
10. Viral load and neuropathology in the SIV model
11. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis
12. AIDS dementia complex and HIV-1 brain infection: Clinical-virological correlations
13. HIV-associated disease of the nervous system: Review of nomenclature and proposal for neuropathology-based terminology- Consensus Report
14. Simian immunodeficiency virus model of HIV-induced central nervous system dysfunction
15. Early viral replication in the brain of SIV-infected rhesus monkeys
16. Quinolinic acid and lymphocyte subsets in the intrathecal compartment as biomarkers of SIV infection and simian AIDS
17. Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinalfluid and serum of seropositive individuals with and without neurologic abnormalities
18. Impact of various simian immunodeficiency virus variants on induction and nature of neuropathology in macaques
19. Nature and sequence of simian immunodeficiency virus-induced central nervous system lesions: A kinetic study
20. Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs
21. An early increase in somatostatin mRNA expression in the frontal cortex of rhesus monkeys infected with simian immuno-deficiency virus
22. Early viral brain invasion in iatrogenic human immunodeficiency virus infection
23. Different patterns of neuropathological disease in rhesus monkeys infected by simian immunodeficiency virus, and their relation to the humoral immune response
24. Relationship between viral load in blood, cerebrospinal fluid, brain tissue and isolated microglia with neurological disease in macaques infected with different strains of SIV
25. The simian immunodeficiency viruses
26. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy
27. Human immunodeficiency virus infection: Affinity-mediated immunoblot detects intrathecal synthesis of oligoclonal IgG specific for individual proteins
28. Viral persistence in the CSF under HAART despite adequate plasma response associated with symptomatic HIV-1 infection of the CNS
29. Cerebrosopinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome
30. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources
31. Malignant lymphoma associated with human AIDS and with SIV-induced immunodeficiency in macaques
32. Highly active antiretroviral treatment in HIV infection: Benefits for neuropsychological function
33. Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys
34. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS
35. Neuropathologic aspects of lentiviral infections
36. Secretion of neurotoxins by mononuclear phagocytes infected with HIV
37. Clinical-neuropathologic correlation in HIV-associated dementia
38. Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia
39. Early brain injury in the SIV-macaque model of AIDS
40. Intrathecal synthesis of antibodies to HTLV-III in patients without AIDS or AIDS-related complex
41. A pathogenic treshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques
42. Pathogenesis of lentivirus infections
43. AIDS as a zoonosis: Scientific and public health implications
44. Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid quinolinic acid and kynurenic acid
45. Isolation of HTLV-III from cerebrospinal fluid and neural tissue of patients with neurologic syndromes related to the acquired immunodeficiency syndrome
46. Early physiological abnormalities after simian immunodeficiency virus infection
47. Simian virus 40-induced disease in rhesus monkeys with simian acquired immunodeficiency syndrome
48. Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection
49. Detection of a vigorous HIV-1-specific T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex
50. Animal model of mucosally transmitted human immunodeficiency virus type 1 disease: Intravaginal and oral deposition of simian/human immunodeficiency virus in macaques results in systemic infection, elimination of CD4+ T cells, and AIDS
51. Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome
52. Drug concentration heterogeneity facilitates the evolution of drug resistance
53. Comparatative biology of natural and experimental SIVmac infection in macaque monkeys: A review
54. The effects of human immunodeficiency virus in the central nervous system
55. Monoamine metabolite levels in CSF of SIV-infected rhesus monkeys (Macaca mulatta)
56. Involvment of microglia in cerebrospinal fluid glutamate increase in SIV-infected rhesus monkeys (macaca mulatta)
57. Brain choline acetyltransferase reduction in SIV infection. An index of early dementia?
58. Selegiline completely restores choline acetyltransferase activity deficits in simian immunodeficiency infection
59. Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration
60. Human immunodeficiency virus-1 infection of the nervous system: An autopsy study of 268 adult, pediatric, and fetal brains
61. Pathology of simian immunodeficiency virus induced disease
62. Retroviral infections of the CNS of nonhuman primates
63. Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys
64. Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus
65. Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation
66. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III
67. Increased expression of nitric oxide synthase and dendritic injury in simian immunodeficiency virus encephalitis
68. Update on current models of HIV-related neuronal injury: Platelet-activating factor, arachidonic acid and nitric oxide
69. Dopamine systems in human immunodeficiency virus-associated dementia
70. Blood-brain barrier disruption in simian immunodeficiency virus encephalitis
71. Hippocampal neuronal atrophy occurs in rhesus macaques following infection with simian immunodeficiency virus
72. Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro
73. Alterations in blood-brain barrier glucose transport in SIV-infected macaques
74. Simple and choice reaction time performance in SIV-infected rhesus macaques
75. Motor skill impairment in SIV-infected rhesus macaques with rapidly and slowly progressing disease
76. Highly activated cd8(+) t cells in the brain correlate with early central nervous system dysfunction in simian immunodeficiency virus infection
77. Pathogenesis of HIV-1 associated neurodegeneration
78. Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings
79. Dementia in AIDS patients: Incidence and risk factors
80. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain
81. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
82. Progressive dendritic pathology in cynomolgus macaques infected with simian immunodeficiency virus
83. Cognitive and motor impairments associated with SIV infection in rhesus monkeys
84. The AIDS dementia complex. II. Neuropathology
85. The AIDS dementia complex. I. Clinical features
86. AIDS dementia is associated with massive, activated HIV-1 infection and concomittant expression of several cytokines
87. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system
88. The development of animal model systems for HIV-1 encephalitis and its associated dementia
89. The feline model of neuroAIDS: Understanding the progression towards AIDS dementia
90. Neurologic complications of HIV infection
91. The brain in AIDS: Central nervous system HIV-1 infection and AIDS dementia complex
92. Microglia-passaged simian immunodeficiency virus induces neurophysiological abnormalities in monkeys
93. Clinical features and predictive markers of disease progression in cynomolgus monkeys experimentally infected with simian immunodeficiency virus
94. Morphological correlates of neurological dysfunction in macaques infected with neurovirulent simian immunodeficiency virus
95. Cytopathologic and neurochemical correlates of progression to motor/cognitive impairment in SIV-infected rhesus monkeys
96. Zidovudine treatment prolongs survival and decreases virus load in the central nervous system of rhesus macaques infected perinatally with simian immunodeficiency virus
97. Auditory brainstem responses in a Rhesus Macaque model of neuro-AIDS
98. Motor evoked potentials in a rhesus macaque model of neuro-AIDS
99. Sensory evoked potentials in SIV-infected monkeys with rapidly and slowly progressing disease
100. Simian immunodeficiency virus-induced meningoencephalitis: Natural history and retrospective study
101. Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors
102. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998
103. Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus
104. Homozygosity for a conserved Mhc class II DQ-DRB haplotype is associated with rapid disease progression in SIV-infected macaques: Results from a prospective study
105. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
106. Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy
107. The encephalopathy associated with murine acquired immunodeficiency syndrome
108. Pathology of HIV-1 infection of the central nervous system. A review
109. Neuropathology and pathogenesis of SIV infection of the central nervous system
110. Comparison of simian immunodeficiency virus and human immunodeficiency virus encephalitides in the immature host
111. Serial pathogenesis study of SIV brain infection
112. Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytetropic parental virus: Pathogenesis of infection in macaques
113. Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus
114. Dynamics of the immune system response in cerebrospinal fluid and blood of SIVmac-infected rhesus monkeys
115. Protective role of the virus-specific immune response for development of severe neurologic signs in simian immunodeficiency virus-infected macaques
116. Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection
117. Central nervous system damage produced by expression of the HIV-1 coat protein gp 120 in transgenic mice
118. Detection of HIV-1 gene sequences in hippocampal neurons isolated from postmortem AIDS brains by laser capture microdissection
119. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment
120. 1H magnetic resonance spectroscopy reveals neuronal injury in a simian immunodeficiency virus macaque model
121. Animal models recapitulate aspects of HIV/CNS disease
122. HAART is neuroprophylactic in HIV-1 infection
123. Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques
124. Transfer of neuropathogenic simian immunodeficiency virus with naturally infected microglia
125. Plasma viremia in macaques infected with simian immunodeficiency virus: Plasma viral load early in infection predicts survival
126. Cortical astrocytosis in juvenile rhesus monkeys infected with simian immunodeficiency virus
127. Simian immunodeficiency virus encephalitis in rhesus macaques is associated with rapid disease progression
128. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome
129. Cellular localisation of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients
130. Neocortical damage during HIV infection
131. Distribution of brain HIV load in AIDS
132. HIV mediates a productive infection of the brain
133. Replication and distribution of SIVmac251 RNA in the brain of infected rhesus macaques
134. Simian immunodeficiency virus/delta-induced immunodeficiency disease in rhesus monkeys: Relation of antibody response and antigenemia
135. The HIV-1 associated dementia complex: A metabolic encephalopathy fueled by viral replication in mononuclear phagocytes
136. Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV
137. High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis